Cargando…

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Detalles Bibliográficos
Autores principales: Verhagen, Nathaniel B., Koerber, Nicolas K., Szabo, Aniko, Taylor, Bradley, Wainaina, J. Njeri, Evans, Douglas B., Kothari, Anai N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734328/
https://www.ncbi.nlm.nih.gov/pubmed/36479662
http://dx.doi.org/10.1245/s10434-022-12916-z
_version_ 1784846564304355328
author Verhagen, Nathaniel B.
Koerber, Nicolas K.
Szabo, Aniko
Taylor, Bradley
Wainaina, J. Njeri
Evans, Douglas B.
Kothari, Anai N.
author_facet Verhagen, Nathaniel B.
Koerber, Nicolas K.
Szabo, Aniko
Taylor, Bradley
Wainaina, J. Njeri
Evans, Douglas B.
Kothari, Anai N.
author_sort Verhagen, Nathaniel B.
collection PubMed
description
format Online
Article
Text
id pubmed-9734328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97343282022-12-12 Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery Verhagen, Nathaniel B. Koerber, Nicolas K. Szabo, Aniko Taylor, Bradley Wainaina, J. Njeri Evans, Douglas B. Kothari, Anai N. Ann Surg Oncol Aso Research Letter Springer International Publishing 2022-12-07 2023 /pmc/articles/PMC9734328/ /pubmed/36479662 http://dx.doi.org/10.1245/s10434-022-12916-z Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Aso Research Letter
Verhagen, Nathaniel B.
Koerber, Nicolas K.
Szabo, Aniko
Taylor, Bradley
Wainaina, J. Njeri
Evans, Douglas B.
Kothari, Anai N.
Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title_full Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title_fullStr Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title_full_unstemmed Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title_short Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery
title_sort vaccination against sars-cov-2 decreases risk of adverse events in patients who develop covid-19 following cancer surgery
topic Aso Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734328/
https://www.ncbi.nlm.nih.gov/pubmed/36479662
http://dx.doi.org/10.1245/s10434-022-12916-z
work_keys_str_mv AT verhagennathanielb vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT koerbernicolask vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT szaboaniko vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT taylorbradley vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT wainainajnjeri vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT evansdouglasb vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT kotharianain vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery
AT vaccinationagainstsarscov2decreasesriskofadverseeventsinpatientswhodevelopcovid19followingcancersurgery